RIPK1 and neoplasm: Unlike mice with complete RIPK1 deletion, T cells in Ripk1K45A/K45A mice lack RIPK1 kinase activity but retain their scaffold function, potentially leading to more stable peripheral T cells and enhancing the likelihood of ICD in tumour cells.